Talk Evidence covid-19 update - dexamethosone, testing, rehabilitation after covid. - a podcast by The BMJ

This week we're looking beyond the press release for dexamethasone, the long awaited review of antibody testing, and how well people are recovering after surviving acute covid-19.


(2.36) The preprint for dexamethasone is finally out - considerably after the press release. Carl digs into it to find out how good the news actually is.(8.49) There are a couple of newly published systematic reviews on antibody testing, so we return to our testing guru Jon Deeks - professor of biostatistics at the University of Birmingham to give us an update.

(23.52)Covid-19, it became apparent as the pandemic grew, was more than a respiratory disease - there are systemic effects on almost all organs. As people are recovering from the worst ravages of the disease, the long term consequences of those effects are becoming more clear - Lynne Turner-Stokes, professor of rehabilitation medicine at King's College London.Reading list;

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Reporthttps://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1Cochrane review of antibody tests for covid-19DOI: 10.1002/14651858.CD013652

British society of rehabilitation medicine guidelines for rehab after covid-19.

https://www.bsrm.org.uk/downloads/covid-19bsrmissue1-published-27-4-2020.pdf

Further episodes of Talk Evidence

Further podcasts by The BMJ

Website of The BMJ